PMID- 29040365 OWN - NLM STAT- MEDLINE DCOM- 20180518 LR - 20211204 IS - 1745-7270 (Electronic) IS - 1672-9145 (Linking) VI - 49 IP - 12 DP - 2017 Dec 1 TI - Role of the Akt/mTOR signaling pathway in human papillomavirus-associated nasal and sinonasal inverted papilloma. PG - 1067-1074 LID - 10.1093/abbs/gmx108 [doi] AB - Nasal and sinonasal inverted papilloma (NSIP) is a benign tumor in which surface epithelial cells grow downward into the underlying supportive tissue with varying degrees of metaplasia. Human papillomavirus (HPV) has been proposed as the causal agent in the pathogenesis of this disease. Many studies have shown that HPV can activate the Akt/mechanistic target of rapamycin (mTOR) signaling pathway, but the role of this pathway in HPV-associated NSIP is largely unknown. In this study, we enrolled 40 control tissue samples and 80 NSIP tissue samples. HPV genotyping showed that 47 of the 80 examined cases of NSIP were HPV-positive (58.8%), and the most common subtype was HPV11 (20/53, 37.7%). The immunohistochemistry showed statistically significant differences in phosphorylated Akt and phosphorylated S6 ribosomal protein staining among control samples, HPV-positive NSIP and HPV-negative NSIP. The HPV11 L1-L2 plasmid increased the proliferation of normal human nasopharyngeal epithelial NP69-SV40T cells and human nasopharyngeal cancer CNE1 cells. Meanwhile, rapamycin, an mTOR inhibitor, reversed the increased cell proliferation induced by the HPV11 L1-L2 plasmid. Western blot analysis showed that Akt/mTOR/S6 were overexpressed in NP69-SV40T cells and CNE1 cells infected with the HPV11 L1-L2 plasmid. These data demonstrate that HPV promotes cell proliferation through the Akt/mTOR signaling pathway in NSIP. CI - (c) The Author 2017. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Liu, Yongliang AU - Liu Y AD - Department of Otolaryngolgogy, Qilu Hospital of Shandong University, Jinan, China. AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Duan, Lihua AU - Duan L AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Tian, Jie AU - Tian J AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Song, Daoliang AU - Song D AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Zhang, Min AU - Zhang M AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Zhao, Shenlin AU - Zhao S AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Yin, Zhaofu AU - Yin Z AD - Department of Otolaryngolgogy, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Xiang, Xinxin AU - Xiang X AD - Central of Translation Medicine, Zibo Central Hospital affiliated to Shandong University, Zibo, China. FAU - Li, Xuezhong AU - Li X AD - Department of Otolaryngolgogy, Qilu Hospital of Shandong University, Jinan, China. LA - eng PT - Journal Article PL - China TA - Acta Biochim Biophys Sin (Shanghai) JT - Acta biochimica et biophysica Sinica JID - 101206716 RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Cell Proliferation MH - Female MH - Genotype MH - Humans MH - Male MH - Middle Aged MH - Nose Neoplasms/*etiology/virology MH - Papilloma, Inverted/*etiology/virology MH - Papillomaviridae/genetics/*isolation & purification MH - Proto-Oncogene Proteins c-akt/*physiology MH - Retrospective Studies MH - Signal Transduction/*physiology MH - TOR Serine-Threonine Kinases/*physiology MH - Young Adult OTO - NOTNLM OT - Akt OT - cell proliferation OT - human papillomavirus (HPV) OT - mechanistic target of rapamycin (mTOR) OT - nasal and sinonasal inverted papilloma (NSIP) EDAT- 2017/10/19 06:00 MHDA- 2018/05/19 06:00 CRDT- 2017/10/18 06:00 PHST- 2017/05/12 00:00 [received] PHST- 2017/10/19 06:00 [pubmed] PHST- 2018/05/19 06:00 [medline] PHST- 2017/10/18 06:00 [entrez] AID - 4523732 [pii] AID - 10.1093/abbs/gmx108 [doi] PST - ppublish SO - Acta Biochim Biophys Sin (Shanghai). 2017 Dec 1;49(12):1067-1074. doi: 10.1093/abbs/gmx108.